Skip to content

Legionella IgG/IgM ELISA Test System

by Armkel, LLC 510(k)

Active United States

510(k) K963318

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK963318 Date3 Mar 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
LHL
Device Class
Class II
Regulation
21 CFR Part 866.3300
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Legionella IgG/IgM ELISA Test System is an in vitro diagnostic device designed for the qualitative detection of total IgG/IgM antibodies to Legionella pneumophila (serogroups 1-6) in patient serum. The test utilizes antigen-coated microtiter wells to capture specific antibodies, which are then bound by enzyme-labeled anti-human IgG/IgM conjugate. A color change proportional to antibody concentration occurs upon substrate addition, with photometric measurement providing the final result.

This test system is supplied as a kit and is intended for single-use in clinical laboratory settings. It is not MRI safe and requires appropriate storage conditions as specified by the manufacturer. The device has received FDA 510(k) clearance with product code LHL and is classified as Class II under regulation number 866.3300.

Other devices from Armkel, LLC

See all devices from Armkel, LLC →

Questions

AI-generated answers, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the purpose of the Legionella IgG/IgM ELISA Test System?

    The Legionella IgG/IgM ELISA Test System is an in vitro diagnostic device designed for the qualitative detection of total IgG/IgM antibodies to Legionella pneumophila (serogroups 1-6) in patient serum, aiding in the diagnosis of Legionella infections.

  • How is the Legionella IgG/IgM ELISA Test System supplied and used?

    The test system is supplied as a kit and is intended for single-use in clinical laboratory settings. It utilizes antigen-coated microtiter wells to capture specific antibodies, which are then bound by enzyme-labeled anti-human IgG/IgM conjugate, with results determined by photometric measurement after substrate addition.

  • What are the storage requirements and regulatory status of this test system?

    The device requires appropriate storage conditions as specified by the manufacturer and is not MRI safe. It has received FDA 510(k) clearance with product code LHL and is classified as Class II under regulation number 866.3300.

  • What Legionella serogroups does this test detect?

    The Legionella IgG/IgM ELISA Test System is designed for the qualitative detection of total IgG/IgM antibodies to Legionella pneumophila across serogroups 1-6, providing comprehensive detection for diagnostic purposes.